Don’t Jump to Voquezna for Erosive GERD

January 2024

Rx vonoprazan (Voquezna) will be touted as the first acid suppressant with a new mechanism of action in over 30 years.

It’s the first potassium-competitive acid blocker (PCAB)...and is now approved for erosive esophagitis.

Think of vonoprazan as a “fancy PPI”...with some differences.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote